Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Government
May 02, 2019 03:46 PM

CBO predicts drug rebate would increase Medicare, Medicaid spending

Robert King
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Medicare spending would climb by $187 billion and Medicaid by $7 billion over the next decade if the CMS finalizes a rule to get rid of the safe harbor for rebates for Part D drugs, according to an analysis from the Congressional Budget Office.

    The figure is slightly below the $196 billion in new spending over the next decade that the CMS' Office of the Actuary predicted earlier this year.

    The Trump administration proposed replacing the safe harbor for rebates from prosecution under the anti-kickback statute with a new one for discounts at the point of sale, by January 2020. The comment period closed last month.

    The CBO, the official congressional scorekeeper, predicted that the increase in Medicare spending will occur via an increase in premiums for Part D plans, which would rise if the rebates are not there to reduce premiums.

    "Because the government subsidizes 74.5% of the basic beneficiary premium, higher premiums would lead to larger federal subsidies, thus increasing federal spending," the CBO said.

    Another reason is due to greater utilization of prescription drugs by Part D beneficiaries because of lower prices at the pharmacy counter.

    "Beneficiaries who do not fill some of their prescriptions because their current out-of-pocket expenses are high would be more likely to fill them and to better adhere to their prescribed drug regimens if their costs were lower, as they would be under the proposed rule," the CBO said.

    Implementation would be costly due to the timing, the agency added.

    The CMS on April 5 instructed Part D plans to submit based on the status of the final rebate rule as of June 3. The CBO said that the rule isn't likely to be finalized by that point and the agency does not "expect plans' bids to reflect the effects of the final rule."

    But the CMS said that if there were a change to the safe harbor rule in 2020 then it would establish a voluntary two-year program where the government absorbs 95% of the losses in 2020.

    "If the proposed rule was implemented, that program would increase federal spending by $10 billion," CBO said.

    HHS Secretary Alex Azar has been a major proponent of the rule, calling the rebates "kickbacks" in multiple speeches and that the rebate structure creates a perverse incentive for drugmakers to raise prices. Because the insurer and pharmacy benefit manager gets a cut of the rebate, the drugmaker must raise the price in order to get their product added to the formulary, HHS charges.

    But insurers and PBMs counter that the rule itself doesn't do anything to force drugmakers to lower prices. They also argue that the rule takes away a key tool that insurers and PBMs use to get manufacturers to lower prices.

    Soon after the analysis was released, opponents of the rule pounced that it was the latest sign that the rule was misguided.

    "If the administration proceeds with a final rule, rather than create an entirely new system, point-of-sale savings should be administered through PBMs, who are uniquely positioned to implement them smoothly and seamlessly," said J.C. Scott, president and CEO of the PBM lobbying group Pharmaceutical Care Management Association, in a statement.

    The CBO said in its analysis that it believes pharmaceutical manufacturers would withhold some of the discounts that they previously negotiated for rebates, "particularly those based on whether a PBM met targets for the share of prescriptions filled with a manufacturer's drug."

    The scorekeeper projects that a drugmaker would withhold about 15% of the current amount they rebate to PBMS and negotiate discounts for the remaining 85%.

    "CBO expects that rather than lowering list prices, manufacturers would offer the renegotiated discounts in the form of chargebacks," the analysis said. Chargebacks are discounts that would be only for prescriptions in Medicare Part D and Medicaid managed care, rather than the entire prescription drug market.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Legal-government-0225
    HHS lawsuit by Democratic AGs aims to stop restructuring, layoffs
    GettyImages-654573744.jpg
    Federal watchdog to retract medical debt collection opinion
    Most Popular
    1
    Downside risk, upside payment highlight new CMS innovation agenda
    2
    UnitedHealth Group CEO Andrew Witty steps down
    3
    AI health risk assessments aim to boost Medicare Advantage pay
    4
    Why healthcare staffing companies are buying competitors
    5
    Docs set for Medicare pay hike under House GOP bill
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content